Matrix metalloproteinases (MMP-2,9) and their tissue inhibitors (TIMP-1,2) as novel markers of stress response and atherogenesis in children with chronic kidney disease (CKD) on conservative treatment

Cell Stress and Chaperones

Volumn 16, Issue 1, 2011, Pages 97-103

  Musiał, Kinga ^a   Zwolińska, Danuta ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Autoimmunity; Heat shock proteins; Inflammation; Lipids; Matrix destruction

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 90 ALPHA; PROTEIN ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHILD; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; DYSLIPIDEMIA; ENDOTHELIAL DYSFUNCTION; ENZYME BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; INFLAMMATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STRESS;

ADOLESCENT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; E-SELECTIN; FEMALE; GLOMERULAR FILTRATION RATE; HSP90 HEAT-SHOCK PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

EID: 79951682872     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-010-0214-x     Document Type: Article

References (43)

1. Addabbo F, Mallamaci F, Leonardis D et al (2007) Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function. Nephrol Dial Transplant 22:3521-3526 (Pubitemid 350212487)
2. Blasi C (2008) The autoimmune origin of atherosclerosis. Atherosclerosis 201:17-32
3. Businaro R, Profumo E, Tagliani A et al (2009) Heat-shock protein 90: a novel autoantigen in human carotid atherosclerosis. Atherosclerosis 207:74-83
4. Caron A, Desrosiers RR, Beliveau R (2005) Ischemia injury alters endothelial cell properties of kidney cortex: stimulation of MMP-9. Exp Cell Res 310:105-116 (Pubitemid 41393692)
5. Castro MM, Rizzi E, Figueiredo-Lopes L et al (2008) Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats. Atherosclerosis 198:320-331 (Pubitemid 351707391)
6. Castro MM, Rizzi E, Rodrigues GJ et al (2009) Antioxidant treatment reduces matrix Metalloproteinase-2-induced vascular changes in renovascular hypertension. Free Rad Biol Med 46:1298-1307
7. Catania JM, Chen G, Parrish AR (2007) Role of matrix Metalloproteinases in renal pathophysiologies. Am J Physiol Ren Physiol 292: F905-F911 (Pubitemid 46393417)
8. Chang HR, Yang SF, Li ML, Lin ChCh, Hsieh YS, Lian JD (2006) Relationships between circulating matrix Metalloproteinase-2 and-9 and renal function in patients with chronic kidney disease. Clin Chim Acta 366:243-248
9. Cheng S, Pollock AS, Mahimkar R, Olson JL, Lovett DH (2006) Matrix Metalloproteinase 2 and basement membrane integrity: a unifying mechanism for progressive renal injury. FASEB J 20: E1248-E1256 (Pubitemid 44933772)
10. Chung AW, Yang HH, Kim JM et al (2009) Upregulation of matrix Metalloproteinase-2 in the arterial vasculature contributes to stiffening and vasomotor dysfunction in patients with chronic kidney disease. Circulation 120:792-801
11. de Nooijer R, Verkleij CJN, von der Thusen HJ et al (2006) Lesional overexpression of matrix Metalloproteinase-9 promotes intraplaque hemorrhage in advanced lesions but not earlier stages of atherogenesis. Arterioscler Thromb Vasc Biol 26:340-346 (Pubitemid 43732197)
12. Dhillon OS, Khan SQ, Narayan HK et al (2010) Matrix Metalloproteinase-2 predicts mortality in patients with acute coronary syndrome. Clin Sci 118:249-257
13. Dulin E, Garcia-Barreno P, Guisasola MC (2010) Extracellular heat shock protein 70 (HSPA1A) and classical vascular risk factors in a general population. Cell Stress Chaperones. doi:10.1007/s12192-010-0201-2
14. El Messal M, Beaudeux JL, Drissi A et al (2006) Elevated serum levels of proinflammatory cytokines and biomarkers of matrix remodeling in never-treated patients with familial hypercholesterolemia. Clin Chim Acta 366:185-189 (Pubitemid 43330981)
15. Hansson J, Lind L, Hulthe J, Sundstrom J (2009) Relations of serum MMP-9 and TIMP-1 levels to left ventricular measures and cardiovascular risk factors: a population-based study. Eur J Cardiovasc Prev Rehab 16:297-303
16. Jefferis BJ, Whincup P, Welsh P et al (2010) Prospective study of matrix Metalloproteinase-9 and risk of myocardial infarction and stroke in older men and women. Atherosclerosis 208:557-563
17. Johnson TS, Haylor JL, Thomas GL et al (2002) Matrix Metalloproteinases and their inhibitors in experimental renal scarring. Exp Nephrol 10:182-195 (Pubitemid 34621596)
18. Johnson JL, George SJ, Newby AC et al (2005) Divergent effects of matrix Metalloproteinases 3, 7, 9 and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries. PNAS 102:15575-15580 (Pubitemid 41528098)
19. Johnson JL, Baker AH, Oka K et al (2006) Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of Metalloproteinase-2. Involvement of macrophage migration and apoptosis. Circulation 113:2435-2444 (Pubitemid 43948051)
20. Kandalam V, Basu R, Abraham T et al. (2010) TIMP-2 deficiency accelerates adverse post-myocardial infarction remodeling because of enhanced MT1-MMP activity despite lack of MMP2 activation. Circ Res (in press)
21. Kol A, Bourcier T, Lichtman AH, Libby P (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103:571-577 (Pubitemid 29094058)
22. Kuzuya M, Nakamura K, Sasaki T et al (2006) Effect of MMP-2 deficiency on atherosclerotic lesion formation in apoE-deficient mice. Arterioscler Thromb Vasc Biol 26:1120-1125 (Pubitemid 43732121)
23. Lods N, Ferrari P, Frey FJ et al (2003) Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix Metalloproteinase activity in patients with glomerulonephritis. J Am Soc Nephrol 14:2861-2872 (Pubitemid 37305649)
24. Luttun A, Lutgens E, Manderveld A et al (2004) Loss of matrix Metalloproteinase-9 or matrix Metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation 109:1408-1414 (Pubitemid 38387828)
25. Madrigal-Matute J, Lopez-Franco O, Blanco-Colio LM et al (2010) Heat shock protein 90 inhibitors attenuate inflammatory responses in atherosclerosis. Cardiovasc Res. doi:10.1093/cvr/cvq046
26. Mitsnefes MM (2005) Cardiovascular disease in children with chronic kidney disease. Adv Chron Kidney Dis 12:397-405 (Pubitemid 41376498)
27. Musiał K, Szprynger K, Szczepańska M, Zwolińska D (2010) The heat shock protein profile in children with chronic kidney disease. Perit Dial Int 30:227-232
28. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
29. Newby AC (2008) Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque stability. Arterioscler Thromb Vasc Biol 28:2108-2114
30. Nilsson J, Hansson GK (2008) Autoimmunity in atherosclerosis: a protective response losing control? J Int Med 263:464-478 (Pubitemid 351533555)
31. Pawlak K, Pawlak D, Mysliwiec M (2007) Serum matrix Metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients. Atherosclerosis 190:199-204 (Pubitemid 44908316)
32. Peiskerova M, Kalousova M, Kratochvilova M et al (2009) Fibroblast growth factor 23 and matrix-Metalloproteinases in patients with chronic kidney disease: are they associated with cardiovascular disease? Kidney Blood Press Res 32:276-283
33. Perschinka H, Mayr M, Millonig G, Mayerl Ch, Van der Zee R, Morrison SG, Morrison RP, Xu Q, Wick G (2003) Crossreactive B-cell epitopes of microbial and human heat shock protein 60/65 in atherosclerosis. Arterioscler Thromb Vasc Biol 23:1060-1065 (Pubitemid 36713561)
34. Pockley AG, Bulmer J, Hanks BM, Wright BH (1999) Identification of human heat shock protein 60 (Hsp60) and anti-Hsp60 antibodies in the peripheral circulation of normal individuals. Cell Stress Chaperones 4:29-35 (Pubitemid 29178591)
35. Preston GA, Barrett CV, Alcorta DA et al (2002) Serum matrix Metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levels. Nephron 92:817-823 (Pubitemid 36151362)
36. Rigano R, Profumo E, Buttari B et al (2007) Heat shock proteins and autoimmunity in patients with carotid atherosclerosis. Ann NY Acad Sci 1107:1-10 (Pubitemid 47528776)
37. Rysz J, Banach M, Stolarek RA et al (2007) Serum matrix Metalloproteinases MMP-2 and MMP-9 and Metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. J Nephrol 20:444-452 (Pubitemid 350081499)
38. Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Willeit J, Wick G (1995) Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 96:2569-2577
39. Valentin F, Bueb JL, Kieffer P et al (2005) Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam Clin Pharmacol 19:661-667 (Pubitemid 43822001)
40. Wick G, Knoflach M, Xu Q (2004) Autoimmune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 22:361-403 (Pubitemid 38680427)
41. Wu T, Tanguay RM (2006) Antibodies against heat shock proteins in environmental stresses and diseases: friend or foe? Cell Stress Chaperones 11:1-12 (Pubitemid 43363820)
42. Zhang Y, McCluskey K, Fujii K, Wahl LM (1998) Differential regulation of monocyte matrix Metalloproteinase and TIMP-1 production by TNF-α, granulocyte-macrophage CSF, and IL-1 |3 through prostaglandin-dependent and-independent mechanisms. J Immunol 161:3071-3076 (Pubitemid 28425734)
43. Zhang X, Xu Z, Zhou L et al (2010) Plasma levels of Hsp70 and anti-Hsp70 antibody predict risk of acute coronary syndrome. Cell Stress Chaperones. doi:10.1007/s12192-010-0180-3